BIS Healthcare vertical is uniquely positioned to provide market intelligence solutions and research reports on emerging healthcare technologies such as precision medicine, life sciences and biopharma, MedTech, robotics and imaging, and digital health, thereby covering the entire spectrum of the healthcare industry.
These reports and research solutions provide its clients with the most valuable and actionable information and a multi-angle approach to data intelligence that allows them to access in-depth analyses of the markets. Analysts at BIS Healthcare follow a structured and unique research methodology and are deeply committed to delivering the most reliable and accurate assessments available, based on a strong foundation both for qualitative as well as quantitative research.
The C-Arms Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 4.82% during the forecast period from 2019 to 2029. The C-arms Market Size is valued at $1,617.4 million in 2018.
The aim of the population genomic initiatives implemented across the globe is to develop the biobank of genomic datasets facilitating the understanding of interaction between the gene and the phenotypic expression.
The global digital respiratory devices market analysis done by BIS Research highlights that the market was valued at approximately $8.5 million in 2018 and is anticipated to reach $334.0 million by 2029.
The global pharmacogenomics market has been witnessing a steady growth since the end of the Human Genome Project in 2003. The market is expected to continue to grow with a double digit CAGR of 6.98% during the forecast period, 2019-2028.
The global neurostimulation devices market has been witnessing annual growth rate of approximately 13.14% in past three years (2015-2018), and the market is expected to continue to grow with the CAGR of 9.23% during the forecast period, 2019-2024.
The Latin America cell culture market has been witnessing a steady growth. The market is expected to continue to grow with a single digit CAGR of 6.20% during the forecast period, 2018-2025. Growing at the fastest CAGR of 6.48% during the forecast period of 2018-2025, the consumables segment is anticipated to generate a value of $811.5 million in 2025.
The global molecular diagnostics market has been witnessing a steady growth since the end of the Human Genome Project in 2003. The market is expected to continue to grow with a double digit CAGR of 10.89% during the forecast period, 2018-2028.
The global human microbiome modulators market has been witnessing a steady annual growth rate of approximately 6.08% in past three years (2015-2017), and the market is expected to continue to grow with a double digit CAGR of 16.29% during the forecast period, 2018-2023.
As of 2017, the global joint reconstruction market was estimated to be $16.82 billion and is expected to reach a value of $26.81 billion by the end of 2025, growing with a double digit CAGR during the forecast period.
The global surgical robotics market is expected to reach $11.65 billion by 2025. The market consists of various product segments such as surgical systems, instruments and accessories and maintenance services.
The global NGS informatics and clinical genomics market encompasses major regions such as North America, Europe, Asia-Pacific, Middle East and Africa, and Rest-of-the-World (RoW). North America is the leading region in the NGS informatics and clinical genomics market accounting for approximately 45.45% and has an estimated value of $380.0 million (as of 2017).
The global enzymes market was valued $6.57 billion in 2017 and is anticipated to reach $10.63 billion by 2025. The growing demand for enzymes in various industries is the major reason for the growth of this market.
The global image guided interventions market is segment into five different parts such as by product type, by modality, by application, by end user, and by region. The global image guided interventions market is expected to reach $6,509.3 million by 2028.
The global companion diagnostics market is expected to reach $4.1 billion by 2025. With increasing demand for NGS-based companion diagnostics, the global CDx market is expected to witness double digit growth rate during the forecast period 2018-2025.
The global ambulatory device market is expected to reach $17.55 billion by 2028.With the increasing demand for the technological advancements across various segments of the ambulatory devices, the ambulatory device market is expected to witness rapid growth in the future.
The global edge analytics market was estimated to be $2.14 billion in 2017, and is expected to reach $13.44 billion by the end of 2025, registering a CAGR of 22.2% during the forecast period, 2018-2025.
The global cell free DNA isolation and extraction market is anticipated to grow over $442.8 Million with 14,638.3 Thousand units by 2026, aided by the rising demand for non-invasive prenatal testing among high risk pregnant women and increased demand for liquid biopsy.
The global medical lighting technologies market is expected to account for $2.76 billion by 2026. Furthermore, as per the installation volume data, the total installation of surgical lighting systems is expected to grow at the CAGR of 5.2% during the forecast period, 2018-2025.
The global injectable drug delivery market was estimated at $16.73 billion in 2016 and is estimated to grow over $37.47 billion by 2025. The rise in the geriatric population along with the increased prevalence of chronic diseases is expected to boost the demand for the injectable drug delivery devices and drive growth of the global market.
The global biosensors market was valued $1.46 billion in 2017. With the growing prominence of point of care testing services, aided by rising geriatric population and rapid incorporation of biosensing technologies in non-medical applications, the global biosensors market is anticipated to witness an impressive double-digit growth rate.
The global blockchain in the healthcare market is expected grow at a CAGR of 63.85% from 2018 to 2025, to reach a value of $5.61 billion by 2025. The use of blockchain for healthcare data exchange will contribute the largest market share throughout the forecast period, reaching a value of $1.89 billion by 2025.
Genetic diseases have been responsible for approximately 25% of the global economic burden for diseases. The advent of CRISPR technology has transformed the field of genome editing and paved pathways for development of several gene therapies for the treatment of various genetic diseases. The global CRISPR technology market is expected to reach $10.55 billion by 2027.
The global electrosurgical devices market was estimated at $2.64 billion in 2016 and is anticipated to reach $4.33 billion by 2023. With the increasing demand for minimally invasive surgeries, increasing geriatric population with higher life expectancy, and new product launches by several conglomerate companies, the electrosurgical devices market is expected to witness moderate growth.
The global big data in healthcare market was estimated to be worth $14.25 billion in 2017, and is expected to grow over $68.75 billion by 2025, driven by growing adoption of cloud storage and analytics, large scale government initiatives to promote data driven innovation, and growing demand for wearables, and mhealth applications among consumers.
The global medical assistive technologies market is expected to grow over $24.41 Billion by 2025, driven by advancements in the field of the medical assistive technologies, growing disability and injury rate, increasing geriatric population, and rising demand of technologically advanced assistive devices.
The global drug infusion systems market was estimated to be $8.1 billion in 2016 and is estimated to grow over $14.7 billion by 2025. The rise in the geriatric population along with the increased prevalence of chronic diseases is expected to boost the demand for drug infusion systems and drive the global market towards rapid growth. The drug infusion systems market presents with opportunities to change the treatment options according to the needs of the patient.
The global mobile medical apps market was estimated at $1.40 billion in 2016, and is anticipated to reach $11.22 billion by 2025, driven by the emergence of high speed networks, greater accessibility, security and affordability of smartphones.
The global laboratory automation systems market was estimated at $5.05 billion in 2016 and is anticipated to reach $9.55 billion by 2026. With the increasing demand for genomics and proteomics research-based technologies and diagnostics tests, the laboratory automation systems market is expected to witness moderate growth.
The global surgical robotics market is expected to reach $12.60 billion by 2025. The market consists of various product segments such as surgical systems, instruments and accessories and maintenance services. The instruments and accessories segment had the highest market value in 2016, growing at the CAGR of 11.4% during the forecast period 2017-2025. However, services (maintenance and up-gradation) are expected to grow at the highest CAGR of 12.9% during the forecast period 2017-2025.
The regenerative medicines market generated $17.03 billion revenue in 2016. The North America regenerative medicines market currently holds 39% percent of the global regenerative medicines market. Technological innovations across the various segments of the regenerative medicine have propelled growth in the recent past in the region.
Medical image analysis software application perform a vital role after the image has been acquired in digital form is the analysis of the acquired image to extract medically or clinically relevant information for diagnosis & treatment planning. It can be either for a general purpose or designed for any specific medical application area.
The global CDSS market is expected to reach a value $10.82 billion by the end of 2025 and is driven by the increasing demand for IT solutions to effectively reduce the healthcare costs. The rising number of chronic diseases and technical advancements in big data such as use of machine learning and artificial intelligence (AI) are further propelling the growth of the market.
The global precision medicine market was dominated by the oncology segment in 2016. The oncology market is expected to grow with a CAGR of 10.4% from 2017 to 2026. The rise in the number of cancer cases has significantly increased the global economic burden and is estimated to be approximately $4 trillion in 2025.
The global next generation market was estimated at $4.14 billion in 2016 and is estimated to grow over $11.92 billion by 2024. The global next generation sequencing market is expected to grow with a double digit compound annual growth rate between the years 2017 and 2024.
The global liquid biopsy market is anticipated to grow over $4,434 million by 2025. With the growing prominence for non-invasive diagnostic procedures, the global liquid biopsy market is expected to register an impressive double digit growth rate in the forecast period 2016-2025.
The global women’s health market was estimated at $30.88 billion in 2016 and is estimated to grow over $42.12 billion by 2023. The rising geriatric population among women leading to higher incidence rate of menopause and related diseases is the major factor driving the growth of the market.
The artificial intelligence market in healthcare sector is estimated to reach $XX million by 2025 at a CAGR of XX% through the forecast period. This growth in the artificial intelligence market in healthcare sector is attributed to the increasing need for driving huge amount of complex data which can be achieved with the usage of artificial intelligence.
The global population health management solution market can be segmented on the basis of type of component into software and services. The software segment is the leading segment of the PHM market considering the huge demand for PHM tools and platforms to collect, analyse and interpret clinical data to enable improved patient outcomes.
The cancer imaging systems market is growing at an exponential rate with the increasing incidence of various types of cancer and active research and developmental activities dedicated to the continuous advancement in the imaging modalities. With the rising incidence of various types of cancer such as breast, lung, prostate and colorectal, cancer is the primary responsible factor for the growth of cancer imaging systems market.
The pharmaceuticals and biotechnology as well as food and beverages industry are the largest end users in industrial microbiology market due to increasing drug development, growing demand of pathogen testing in food products and increase in significance of industrial food and safety.
The global high acuity information solutions market is expected to reach $13.69 billion by the end of 2025 growing at a CAGR of 8% during the forecast period, 2017-2025. The major factors facilitating the growth of this market include significant emphasis on reducing the number of deaths due to medical errors, need for better workflow management under high acuity settings, rising government initiatives to reduce healthcare costs.
The global next generation implants market is estimated to grow over $3.9 billion by 2023. On the other hand, the conventional implants market is estimated to grow over $103 billion in 2023. On the basis of application, the market is segmented into orthopedic, cardiovascular, dental, ocular and other implants.
The global healthcare RFID market is anticipated to reach $4.1 billion by 2021 growing at a CAGR of 21.64% during the forecast period between 2017-2021. The growth in RFID in healthcare market over the period 2017-2021 is expected to be primarily supplemented by factors such as increasing need of patient monitoring due to increasing geriatric population, advancement of product development and increasing support by government for adoption of RFID technology.
The global biologics drug discovery market was estimated to be $8.9 billion in 2016 and is estimated to grow over $22.7 billion by 2025. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine is expected to fuel the demand for biologics drugs in the future.
The global biologics market generated a revenue of $238.8 billion in 2016. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine is expected to fuel the demand for biologics drugs in the future.
The global computer aided diagnostics market is forecast to reach $XX million by 2025. The CADx market broadly focuses on major application areas (oncology, cardiovascular, and neurological) and various imaging modalities (mammography, MRI, tomosynthesis, etc.). The application segment of this market comprise of oncology and other diseases (neurological, cardiovascular and musculoskeletal) application areas.
The global pacemakers and ICDs market are expected to grow at a CAGR of 4.6% and 4.8% from 2017 to 2023. The factors includes revenue growth by dual chamber ICDs and Leadless Pacemakers as well as MRI Compatible ICD devices.
The global Wound Cleansers Product market is growing at a CAGR of 5.4%. On the basis of wound type, the market has been segmented into acute wounds, non-acute surgical wounds, chronic wounds and others.
The global market for prefilled syringes is expected to grow at a CAGR of 10.75% from 2017 to 2021, to reach a value of $XX million in 2021. In terms of volume, the market for prefilled syringes is anticipated to reach 8320.6 million units in 2021, growing at a CAGR of 12.31% during the forecast period 2017 to 2021.
The global GERD drugs market has a low growth potential in future and will account to $5.38 billion by 2023. Due to side effects of drugs on long term use, patients who fail to respond to medication & the availability of new technology, the device market is set to grow in future.
North America was the largest market for NIPT in 2016 in terms of revenue and volume. The region is expected to retain its leadership position throughout the forecast period as major players in the NIPT market are based in the U.S. (the largest shareholder in North America).
IVD is expected to increase to $76 billion by 2023 and increase its influence over healthcare spending globally. The category’s rate of growth is accelerating due to a number of key macro forces, such as demand from emerging economies, aging population, evolving clinician attitudes, and a much needed push towards theranostics and personalized medicine.
The global incidence rate of jet-lag is still unknown, but it impacts a high percentage of approximately 30 million plus jet travelers who leave the U.S. yearly for destinations that cross five or more time zones. Globally, jet lag affects more than 100 million people annually.
The purpose of the study is to gain a holistic view of global Newborn Screening market in terms of various factors influencing it like recent trends, technological advancements, and regulatory aspects of automation systems.
The global emerging cancer diagnostics market is expected to grow at a CAGR of 13.45% from 2016 to 2023 and reach a figure of $6.34 billion by 2023. The advancements in technology, adoption of biomarker tests, and increasing cancer incidence rate are some of the major driving factors for this market. The global emerging cancer diagnostics market has been classified on the basis of test type, application and geography.
The global advanced wound care market is expected to reach $10,940.7 million in 2022, growing at a CAGR of 5.0% from 2016 to 2022. Advanced wound care dressings accounted for the largest market share of the advanced wound care technology market in 2015.
The global CGM(Continuous Glucose Monitoring) Systems market has been identified as one of the fastest growing industries, owing to the changing dynamics of the legal and regulatory framework and the intense competitive rivalry among a plethora of public companies.
The global IVF market includes pre-treatment drugs and lab equipment, instrument & reagents. In this report the pre-treatment drugs market is not taken into consideration. The global market is expected to grow over $26.08 billion by 2022. IVF Market can be further divided into various segments and sub-segments.
The pharmacovigilance market is expected to reach a market size of $8.23 billion by 2022. Stringent compliance with drug safety regulations and increasing incidents of ADRs are acting as key drivers for the growth of this market.
The global prenatal testing market is growing at a CAGR of 28.85% from 2016 to 2022 and is estimated to grow over $7.2 billion by 2022. Prenatal tests are classified into two main categories viz. Screening and Diagnostics. Both screening and diagnostics have witnessed an exponential growth in procuring treatments for disorders which increased in the past two decades.
The Healthcare IOT Security market is expected to grow at a CAGR 39.44% during the forecast period because of increased connectivity of smart IOT devices with the healthcare organizations for better health management and government support and acknowledgement for IOT Security in the healthcare sector.
Advancement and innovation of new healthcare technologies such as next generation sequencing, high throughput screening (HTS), and Digital PCR are developing the platform for the growth of Pharmacogenomics (PGx) market. The global PGx market is expected to grow over $14.85 billion by 2022.
Prenatal Testing and Newborn Screening is one of the most modernized trends in the healthcare industry which has shown a tremendous level of progress in the last few years. The growth of prenatal and newborn genetic testing market is attributed primarily to a rapid increase in genetic disorders/abnormalities, increase in fetal mortality, and advancement of healthcare technologies. The global prenatal and newborn genetic testing market has a high growth potential in future and will grow over $10.
The healthcare industry is in a period of rapid change. Advancements in the fields of genetics, biomedical, and information technology are paving a way towards effective personalized treatments in accordance to the individual characteristics of the patients. Exploiting these opportunities requires effective usage of Big Data.
With the advancement of drug delivery technologies and blood glucose diagnostic devices, the Diabetic Care market has emerged as a fast developing sector in healthcare. The overall market growth is gaining speed as large number of government initiatives and research & development programs have been launched in the recent years.
Precision medicine is becoming one of the most modernized trends in the healthcare industry showing an incredible growth in the recent years. According to the report put forward by the market research experts of BIS Research, the global precision medicine market is expected to grow over $88 billion by 2022 at an estimated CAGR of 12.60% from 2015 to 2022.
The mHealth services dominated the market in 2014 and are expected to grow over $55.63 billion by the end of the forecast period due to the increasing usage of mHealth solutions by healthcare providers and pharmaceutical companies along with end users (patients). However, device segment is expected to grow in near future with a high CAGR of 38.02%, from 2015 to 2022.